Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trialHiddo J.L. Heerspink, Chris Vercammen, Ricardo Correa-Rotter et al.|The Lancet|2019Cited by 609
Associations Between Albuminuria and Clinical Outcomes in Patients with CKD with and Without Diabetes: New Insights from DAPA-CKDDominique van Mil, Hiddo J.L. Heerspink, Priya Vart et al.|Journal of the American Society of Nephrology|2023Cited by 0